Home › Funds › Ishara Investments LP › CTNM
Ishara Investments LP position in CTNM
CONTINEUM THERAPEUTICS INC · Health Care
Ishara Investments LP reported holding 108,000 shares of CTNM (CONTINEUM THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$1.4M, representing 1.22% of its reported portfolio and ranking #29 among its reported holdings. Ishara Investments LP has disclosed CTNM holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Ishara Investments LP's CTNM position evolved
Ishara Investments LP first disclosed a stake in CTNM in Q1 2026 at 142,000 shares (US$1.9M). The position peaked in Q2 2026 at 205,000 shares, worth US$3.4M. Across 3 filings, Ishara Investments LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 108,000 shares valued at US$1.4M — a reduction of -97,000 shares quarter over quarter.. Notable position changes include a 44% increase in Q2 2026 (shares fell 18% over the following quarter), a 47% trim in Q3 2026 (shares fell 27% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 142.00K | $1.85M | New |
| Q2 2026 | 205.00K | $3.36M | Add |
| Q3 2026 | 108.00K | $1.45M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CTNM and 13F data
CTNM (CONTINEUM THERAPEUTICS INC) is a Health Care company. 58 other funds we track also report a position in CTNM — the largest reported positions include MONTANOVA CAPITAL, LLC (US$46.6M), JOHNSON & JOHNSON (US$26.6M), Trails Edge Capital Partners, LP (US$22.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CTNM
- MONTANOVA CAPITAL, LLC 2.84M sh · $46.57M · Q2 2026
- JOHNSON & JOHNSON 1.98M sh · $26.56M · Q3 2026
- Trails Edge Capital Partners, LP 1.69M sh · $22.73M · Q3 2026
- Versant Venture Management, LLC 1.29M sh · $17.35M · Q3 2026
- GREAT POINT PARTNERS LLC 921.48K sh · $15.10M · Q2 2026
- Ikarian Capital, LLC 807.87K sh · $13.24M · Q2 2026
- Hillhouse Capital (HHLR Advisors) 669.34K sh · $10.97M · Q2 2026
- SECTORAL ASSET MANAGEMENT INC 689.59K sh · $9.25M · Q3 2026
- Red Tree Management, LLC 638.16K sh · $8.56M · Q3 2026
- Boxer Capital Management, LLC 494.00K sh · $8.10M · Q2 2026
- Squadron Capital Management LLC 260.00K sh · $4.26M · Q2 2026
- HighVista Strategies LLC 217.79K sh · $2.92M · Q3 2026
More on Ishara Investments LP
FAQ
How long has Ishara Investments LP held CTNM?
Ishara Investments LP has disclosed CTNM holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Ishara Investments LP's current position in CTNM?
As of Q3 2026, Ishara Investments LP holds 108.00K shares of CTNM (CONTINEUM THERAPEUTICS INC), valued at $1.45M, representing 1.22% of its reported portfolio and ranking #29.
Has Ishara Investments LP been buying or selling CTNM?
In the latest 13F filing (Q3 2026), Ishara Investments LP reduced its position in CTNM. The position peaked in Q2 2026 at 205.00K shares.
Which other funds hold CTNM?
Other major institutional holders of CTNM include MONTANOVA CAPITAL, LLC, JOHNSON & JOHNSON, Trails Edge Capital Partners, LP, among 58 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.